News

OptimizeRx Announces Proposed Public Offering of Common Stock

09 February 2021

ROCHESTER, Mich., Feb. 08, 2021 -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and patients, today announced it has commenced an underwritten public offering of shares of its common stock. OptimizeRx is expected to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock being offered at the public offering price, less underwriting discounts and commissions. All of the shares will be offered by OptimizeRx.

Read press release here.

FIND US AT THE POINT OF CARE

WE INTEGRATE DIRECTLY INTO THE EHR

SCHEDULE A DEMO